ID

40421

Descrizione

A Trial to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0215-0384 Administered to Subjects With Moderate to Severe Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01955603

collegamento

https://clinicaltrials.gov/show/NCT01955603

Keywords

versioni (1)
  1. 19/04/20 19/04/20 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

19 aprile 2020

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Inflammation NCT01955603

Inglese

Eligibility Inflammation NCT01955603

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, age between 18 and 75 years (both years inclusive), for russia only: age between 18-65 years (both years inclusive)
Descrizione

Age | Relationship Russia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C0035970
moderate to severe ra, confirmed by a disease activity score based on 28 joints and c-reactive protein (das28 (crp)) equal to or above 4.5 and a minimum of five tender and five swollen joints based on a 28 joint count (a joint can score as both tender and swollen)
Descrizione

Rheumatoid Arthritis Moderate | Rheumatoid Arthritis Severe | Disease activity score DAS28 | C-reactive protein measurement | Tender 28 joint count | Swollen 28 joint count

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0205081
UMLS CUI [2,1]
C0003873
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C4481729
UMLS CUI [4]
C0201657
UMLS CUI [5]
C2711398
UMLS CUI [6]
C2711873
mtx (10-25 mg/week both inclusive) for at least 16 weeks, with an unchanged dose for at least 6 weeks prior to screening and until randomisation
Descrizione

Methotrexate Dose unchanged U/week

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0025677
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0442739
UMLS CUI [1,4]
C0560588
females who are not of child-bearing potential must have been post-menopausal for at least 1 year confirmed by follicle-stimulating hormone (fsh) equal to or above 26.7 u/l or be surgically sterile
Descrizione

Gender Childbearing Potential Absent | Postmenopausal state | Follicle stimulating hormone measurement | Female Sterilization

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C3831118
UMLS CUI [1,3]
C0332197
UMLS CUI [2]
C0232970
UMLS CUI [3]
C0202022
UMLS CUI [4]
C0015787
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
past or current inflammatory joint disease other than ra (e.g. gout [crystal proven], psoriatic arthritis, juvenile idiopathic arthritis, reactive arthritis or lyme disease
Descrizione

Inflammatory joint disease | Exception Rheumatoid Arthritis | Gout | Arthritis, Psoriatic | Juvenile arthritis | Arthritis, Reactive | Lyme Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0683381
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0003873
UMLS CUI [3]
C0018099
UMLS CUI [4]
C0003872
UMLS CUI [5]
C3495559
UMLS CUI [6]
C0085435
UMLS CUI [7]
C0024198
any active or ongoing chronic infectious disease (e.g. chronic osteomyelitis, chronic pyelonephritis) within 4 weeks prior to randomisation
Descrizione

Chronic infectious disease | Chronic osteomyelitis | Chronic pyelonephritis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151317
UMLS CUI [2]
C0008707
UMLS CUI [3]
C0085697
clinically significant cardiac or cardiovascular disease
Descrizione

Heart Disease | Cardiovascular Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0007222
past or current malignancy
Descrizione

Malignant Neoplasms

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
evaluation of tuberculosis screening indicative of latent or active tuberculosis (tb)
Descrizione

Indication Latent Tuberculosis | Indication Tuberculosis

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C1609538
UMLS CUI [2,1]
C3146298
UMLS CUI [2,2]
C0041296
Ritorna all'inizio della pagina

Similar models

Eligibility Inflammation NCT01955603

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age | Relationship Russia
Item
male or female, age between 18 and 75 years (both years inclusive), for russia only: age between 18-65 years (both years inclusive)
boolean
C0001779 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C0035970 (UMLS CUI [2,2])
Rheumatoid Arthritis Moderate | Rheumatoid Arthritis Severe | Disease activity score DAS28 | C-reactive protein measurement | Tender 28 joint count | Swollen 28 joint count
Item
moderate to severe ra, confirmed by a disease activity score based on 28 joints and c-reactive protein (das28 (crp)) equal to or above 4.5 and a minimum of five tender and five swollen joints based on a 28 joint count (a joint can score as both tender and swollen)
boolean
C0003873 (UMLS CUI [1,1])
C0205081 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C4481729 (UMLS CUI [3])
C0201657 (UMLS CUI [4])
C2711398 (UMLS CUI [5])
C2711873 (UMLS CUI [6])
Methotrexate Dose unchanged U/week
Item
mtx (10-25 mg/week both inclusive) for at least 16 weeks, with an unchanged dose for at least 6 weeks prior to screening and until randomisation
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0442739 (UMLS CUI [1,3])
C0560588 (UMLS CUI [1,4])
Gender Childbearing Potential Absent | Postmenopausal state | Follicle stimulating hormone measurement | Female Sterilization
Item
females who are not of child-bearing potential must have been post-menopausal for at least 1 year confirmed by follicle-stimulating hormone (fsh) equal to or above 26.7 u/l or be surgically sterile
boolean
C0079399 (UMLS CUI [1,1])
C3831118 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0232970 (UMLS CUI [2])
C0202022 (UMLS CUI [3])
C0015787 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Inflammatory joint disease | Exception Rheumatoid Arthritis | Gout | Arthritis, Psoriatic | Juvenile arthritis | Arthritis, Reactive | Lyme Disease
Item
past or current inflammatory joint disease other than ra (e.g. gout [crystal proven], psoriatic arthritis, juvenile idiopathic arthritis, reactive arthritis or lyme disease
boolean
C0683381 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0018099 (UMLS CUI [3])
C0003872 (UMLS CUI [4])
C3495559 (UMLS CUI [5])
C0085435 (UMLS CUI [6])
C0024198 (UMLS CUI [7])
Chronic infectious disease | Chronic osteomyelitis | Chronic pyelonephritis
Item
any active or ongoing chronic infectious disease (e.g. chronic osteomyelitis, chronic pyelonephritis) within 4 weeks prior to randomisation
boolean
C0151317 (UMLS CUI [1])
C0008707 (UMLS CUI [2])
C0085697 (UMLS CUI [3])
Heart Disease | Cardiovascular Disease
Item
clinically significant cardiac or cardiovascular disease
boolean
C0018799 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
Malignant Neoplasms
Item
past or current malignancy
boolean
C0006826 (UMLS CUI [1])
Indication Latent Tuberculosis | Indication Tuberculosis
Item
evaluation of tuberculosis screening indicative of latent or active tuberculosis (tb)
boolean
C3146298 (UMLS CUI [1,1])
C1609538 (UMLS CUI [1,2])
C3146298 (UMLS CUI [2,1])
C0041296 (UMLS CUI [2,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial